Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Bio-pharma Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Bio-pharma Market Performance
• 2.3 USA Bio-pharma Market Performance
• 2.4 Europe Bio-pharma Market Performance
• 2.5 Japan Bio-pharma Market Performance
• 2.6 Korea Bio-pharma Market Performance
• 2.7 India Bio-pharma Market Performance
• 2.8 Southeast Asia Bio-pharma Market Performance
• 2.9 South America Bio-pharma Market Performance

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
• 3.2 China Bio-pharma Market Performance (Volume)
• 3.3 USA Bio-pharma Market Performance (Volume)
• 3.4 Europe Bio-pharma Market Performance (Volume)
• 3.5 Japan Bio-pharma Market Performance (Volume)
• 3.6 Korea Bio-pharma Market Performance (Volume)
• 3.7 India Bio-pharma Market Performance (Volume)
• 3.8 Southeast Asia Bio-pharma Market Performance (Volume)
• 3.9 South America Bio-pharma Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Pfizer
  • 4.1.1 Pfizer Profiles
  • 4.1.2 Pfizer Product Information
  • 4.1.3 Pfizer Bio-pharma Business Performance
  • 4.1.4 Pfizer Bio-pharma Business Development and Market Status
• 4.2 F. Hoffmann-La Roche AG
  • 4.2.1 F. Hoffmann-La Roche AG Profiles
  • 4.2.2 F. Hoffmann-La Roche AG Product Information
  • 4.2.3 F. Hoffmann-La Roche AG Bio-pharma Business Performance
  • 4.2.4 F. Hoffmann-La Roche AG Bio-pharma Business Development and Market Status
• 4.3 Johnson & Johnson Services
  • 4.3.1 Johnson & Johnson Services Profiles
  • 4.3.2 Johnson & Johnson Services Product Information
  • 4.3.3 Johnson & Johnson Services Bio-pharma Business Performance
  • 4.3.4 Johnson & Johnson Services Bio-pharma Business Development and Market Status
• 4.4 Sanofi, Amgen
  • 4.4.1 Sanofi, Amgen Profiles
  • 4.4.2 Sanofi, Amgen Product Information
  • 4.4.3 Sanofi, Amgen Bio-pharma Business Performance
  • 4.4.4 Sanofi, Amgen Bio-pharma Business Development and Market Status
• 4.5 AbbVie
  • 4.5.1 AbbVie Profiles
  • 4.5.2 AbbVie Product Information
  • 4.5.3 AbbVie Bio-pharma Business Performance
  • 4.5.4 AbbVie Bio-pharma Business Development and Market Status
• 4.6 Merck & Co., Inc
  • 4.6.1 Merck & Co., Inc Profiles
  • 4.6.2 Merck & Co., Inc Product Information
  • 4.6.3 Merck & Co., Inc Bio-pharma Business Performance
  • 4.6.4 Merck & Co., Inc Bio-pharma Business Development and Market Status
• 4.7 Biogen Idec
  • 4.7.1 Biogen Idec Profiles
  • 4.7.2 Biogen Idec Product Information
  • 4.7.3 Biogen Idec Bio-pharma Business Performance
  • 4.7.4 Biogen Idec Bio-pharma Business Development and Market Status
• 4.8 Bayer AG
  • 4.8.1 Bayer AG Profiles
  • 4.8.2 Bayer AG Product Information
  • 4.8.3 Bayer AG Bio-pharma Business Performance
  • 4.8.4 Bayer AG Bio-pharma Business Development and Market Status
• 4.9 Eli Lilly and Company
  • 4.9.1 Eli Lilly and Company Profiles
  • 4.9.2 Eli Lilly and Company Product Information
  • 4.9.3 Eli Lilly and Company Bio-pharma Business Performance
  • 4.9.4 Eli Lilly and Company Bio-pharma Business Development and Market Status
• 4.10 Novartis AG GlaxoSmithKline Plc
  • 4.10.1 Novartis AG GlaxoSmithKline Plc Profiles
  • 4.10.2 Novartis AG GlaxoSmithKline Plc Product Information
  • 4.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Business Performance
  • 4.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Business Development and Market Status
• 4.11 Bristol-Myers Squibb Company
• 4.12 AstraZeneca PLC
• 4.13 Johnson & Johnson Services
• 4.20 Novartis AG GlaxoSmithKline Plc

5 Market Performance for Manufacturers

• 5.1 Global Bio-pharma Production (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Bio-pharma Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Bio-pharma Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Bio-pharma Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Global Bio-pharma Market Performance (Production Point)

• 6.1 Global Bio-pharma Production (K Units) and Market Share by Regions 2013-2018
• 6.2 Global Bio-pharma Revenue (M USD) and Market Share by Regions 2013-2018
• 6.3 Global Bio-pharma Price (USD/Unit) by Regions 2013-2018
• 6.4 Global Bio-pharma Gross Margin by Regions 2013-2018

7 Development Trend for Regions (Production Point)

• 7.1 Global Bio-pharma Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
• 7.2 China Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.3 USA Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.4 Europe Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.5 Japan Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.6 Korea Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.7 India Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.8 Southeast Asia Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.9 South America Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

8 Global Bio-pharma Market Performance (Consumption Point)

• 8.1 Global Bio-pharma Consumption and Market Share by Regions 2013-2018
• 8.2 Global Bio-pharma Consumption Value and Market Share by Regions 2013-2018
• 8.3 Global Bio-pharma Price (USD/Unit) by Regions 2013-2018

9 Development Trend for Regions (Sales Point)

• 9.1 Global Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.2 China Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.3 USA Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.4 Europe Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.5 Japan Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.6 Korea Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.7 India Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.8 Southeast Asia Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.9 South America Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018

10 Upstream Source, Technology and Cost

• 10.1 Upstream Source
• 10.2 Technology
• 10.3 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Consumer Analysis

• 12.1 Metabolic Disorders Industry
• 12.2 Oncology Industry
• 12.3 Neurological Disorders Industry
• 12.4 Cardiovascular Diseases Industry

13 Market Forecast 2019-2024

• 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 13.1.1 Global Bio-pharma Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 13.1.2 Global Bio-pharma Production (K Units) and Growth Rate 2019-2024
  • 13.1.3 China Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.4 USA Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.5 Europe Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.6 Japan Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.7 Korea Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.8 India Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.9 Southeast Asia Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.10 South America Bio-pharma Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.2 Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.1 Global Bio-pharma Consumption and Market Share by Regions 2019-2024
  • 13.2.2 Global Bio-pharma Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.3 China Bio-pharma Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.4 USA Bio-pharma Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.5 Europe Bio-pharma Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.6 Japan Bio-pharma Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.7 Korea Bio-pharma Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.8 India Bio-pharma Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.9 Southeast Asia Bio-pharma Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.10 South America Bio-pharma Sales, Sales Value and Growth Rate 2019-2024
• 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
  • 13.3.1 Overall Market Performance
  • 13.3.2 Monoclonal Antibodies Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.3 Recombinant Proteins Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.4 Granulocyte-Colony Stimulating Factor (G-CSF) Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.5 Interferons Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.4 Sales by Application 2019-2024
  • 13.4.1 Overall Market Performance
  • 13.4.2 Metabolic Disorders Sales and and Growth Rate 2019-2024
  • 13.4.3 Oncology Sales and and Growth Rate 2019-2024
  • 13.4.4 Neurological Disorders Sales and and Growth Rate 2019-2024
  • 13.4.5 Cardiovascular Diseases Sales and and Growth Rate 2019-2024
• 13.5 Price (USD/Unit) and Gross Profit
  • 13.5.1 Global Bio-pharma Price (USD/Unit) Trend 2019-2024
  • 13.5.2 Global Bio-pharma Gross Profit Trend 2019-2024

14 Conclusion

Geographically, global Bio-pharma market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Bio-pharma for each application, including
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
Production, consumption, revenue, market share and growth rate are the key targets for Bio-pharma from 2013 to 2024 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.